SCHEMBL8561816

SCHEMBL8561816

CCOC(=O)C(C)Cn1cc(-c2ccccc2)n(-c2ccc3c(c2)CCN(C(=O)C(F)(F)F)CC3)c1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
TMEM97 Q5BJF2 8/20 0.34
SIGMAR1 Q99720 8/20 0.34
HTR1A P08908 2/20 0.34
CHRM5 P08912 2/20 0.34
HRH2 P25021 2/20 0.34
ADRA1D P25100 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2C P28335 2/20 0.34
HRH1 P35367 2/20 0.34
HTR2B P41595 2/20 0.34
SLC6A2 P23975 1/20 0.34
HTR1B P28222 1/20 0.34
HTR1E P28566 1/20 0.34
SLC6A3 Q01959 1/20 0.34
TP53 P04637 2/20 0.33
CHRM4 P08173 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8561814 0.79 ESR1 (0.36) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL8562345 0.73 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL8562282 0.72 ESR1 (0.35) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL8895074 0.72 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL8895079 0.72 ESR1 (0.39) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL8562631 0.69 TMEM97 (0.39) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL7472118 0.69 ESR1 (0.41) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL7560796 0.68 ESR1 (0.42) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL7472374 0.67 TMEM97 (0.43) ESR1ESR2TMEM97SIGMAR1HTR1A
SCHEMBL7474127 0.65 TMEM97 (0.43) ESR1ESR2TMEM97SIGMAR1HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5827849-A HAVING INHIBITORY EFFECT ON INFLAMMATION AND BONE DEGRADATION, ANTITHROMBOTIC, ANTIAGGREGATORY AND TUMOR- OR METASTASIS-INHIBITING EFFECT KARL THOMAE GMBH (DE) 1998-10-27 US disclosed